Viromed Medical AG (ETR:VME)

Germany · Delayed Price · Currency is EUR

7.70

-0.05 (-0.65%)

At close: Aug 5, 2026

Viromed Medical AG Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	7.36	7.36	1.17	-	0
Revenue Growth	-	526.51%	-	-	-
Gross Profit	4.56	4.56	-0.24	0	0
Operating Income	-0.87	-0.87	-3.5	-0.36	-0.16
Net Income	-0.6	-0.6	3.09	-0.11	-0.16
Earnings Per Share	-0.03	-0.03	0.15	-0.01	-
EPS Growth	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	0.36	0.36	0.02	0.2	0.15
Total Debt	0.29	0.29	0.01	0	0
Net Cash (Debt)	0.07	0.07	0.01	0.2	0.15
Net Cash Growth	-48.41%	446.60%	-93.35%	29.78%	-
Net Cash Per Share	0.00	0.00	0.00	0.01	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	3.68	3.68	-0.4
Capital Expenditures	-0.15	-0.15	0
Free Cash Flow	3.53	3.53	-0.4
Free Cash Flow Growth	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	61.92%	61.92%	-20.30%	-	100.00%
Operating Margin	-11.78%	-11.78%	-297.91%	-	-748480.00%
Pretax Margin	-9.42%	-9.42%	-350.27%	-	-749146.46%
Profit Margin	7.71%	7.71%	-263.22%	-	-749148.00%
FCF Margin	47.98%	47.98%	-33.86%	-	0.00%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
PE Ratio	270.68	-	16.24	-	-
P/FCF Ratio	-	22.83	-	-	-
PS Ratio	32.16	10.95	42.76	-	-